Journal
CELL REPORTS
Volume 5, Issue 1, Pages 207-215Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2013.08.041
Keywords
-
Categories
Funding
- Anderson Cancer Center at Rockefeller University
- Burroughs Wellcome Fund Career Award for Medical Scientists
- Starr Center Consortium grant
- Doris Duke Clinical Scientist Development Award
- National Center for Research Resources [UL1RR024143]
- Sookmyung Women's University [1-1303-0055]
- American Cancer Society-J.T. Tai postdoctoral fellowship
Ask authors/readers for more resources
Holliday junctions (HJs), the DNA intermediates of homologous recombination, need to be faithfully processed in order to preserve genome integrity. In human cells, the BLM helicase complex promotes nonnucleolytic dissolution of double HJs. In vitro, HJs may be nucleolytically processed by MUS81-EME1, GEN1, and SLX4-SLX1. Here, we exploit human SLX4-null cells to examine the requirements for HJ resolution in vivo. Lack of BLM and SLX4 or GEN1 and SLX4 is synthetically lethal in the absence of exogenous DNA damage, and lethality is a consequence of dysfunctional mitosis proceeding in the presence of unprocessed HJs. Thus, GEN1 activity cannot be substituted for the SLX4-associated nucleases, and one of the HJ resolvase activities, either of those associated with SLX4 or with GEN1, is required for cell viability, even in the presence of BLM. In vivo HJ resolution depends on both SLX4-associated MUS81-EME1 and SLX1, suggesting that they are acting in concert in the context of SLX4.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available